Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Poxel Appoints SVP Investor Relations And Public Relations

This article was originally published in Scrip

Executive Summary

Diabetes-focused Poxel has named Jonae R. Barnes senior vice president, investor relations and public relations. Barnes started her career at Sepracor (now Sunovion Pharmaceuticals) where she held various management and executive roles over a 14 year period and most recently she was senior vice president, investor relations, corporate communications and internal communications. She also held senior leadership roles at Agenus.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

SC064824

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel